We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
-0.44%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$109B
AUM Growth
-$4.38B
(-3.9%)
Cap. Flow
-$1.47B
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
24.54%
Holding
1,291
New
49
Increased
537
Reduced
574
Closed
75
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$323M |
| 2 |
GE Vernova
GEV
|
+$279M |
| 3 |
Agnico Eagle Mines
AEM
|
+$259M |
| 4 |
Entergy
ETR
|
+$228M |
| 5 |
Visa
V
|
+$192M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$450M |
| 2 |
NVIDIA
NVDA
|
+$325M |
| 3 |
Eaton
ETN
|
+$317M |
| 4 |
Broadcom
AVGO
|
+$288M |
| 5 |
Invesco Senior Loan ETF
BKLN
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.36% |
| 2 | Technology | 19.34% |
| 3 | Industrials | 10.57% |
| 4 | Healthcare | 9.59% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Rivian
RIVN
$22.5B
| $933K | ﹤0.01% |
74,971
-1,078
| -1% | -$13.6K |
|
|
KRMN
1077
Karman Holdings
KRMN
$6.57B
| $925K | ﹤0.01% |
+27,670
| New | +$893K |
|
1078
Toll Brothers
TOL
$13.9B
| $922K | ﹤0.01% |
8,731
+177
| +2% | +$21.3K |
|
1079
Algoma Steel
ASTL
$416M
| $911K | ﹤0.01% |
167,884
+5,325
| +3% | +$40K |
|
|
LENZ
1080
LENZ Therapeutics
LENZ
$161M
| $895K | ﹤0.01% |
34,828
-68,172
| -66% | -$1.68M |
|
1081
Vanguard Total World Stock ETF
VT
$77.7B
| $889K | ﹤0.01% |
7,663
-252
| -3% | -$30.2K |
|
1082
Corebridge Financial
CRBG
$14.2B
| $888K | ﹤0.01% |
28,123
-534,577
| -95% | -$17.3M |
|
1083
BioLife Solutions
BLFS
$1.56B
| $887K | ﹤0.01% |
+38,820
| New | +$1.02M |
|
1084
Roku
ROKU
$21.7B
| $886K | ﹤0.01% |
12,580
-158,073
| -93% | -$12.6M |
|
|
SVM
1085
Silvercorp Metals
SVM
$2.07B
| $880K | ﹤0.01% |
228,334
+4,342
| +2% | +$15.3K |
|
1086
DT Midstream
DTM
$13.8B
| $878K | ﹤0.01% |
9,104
-16,524
| -64% | -$1.65M |
|
1087
Diageo
DEO
$49.5B
| $877K | ﹤0.01% |
8,370
-11
| -0.1% | -$1.24K |
|
1088
Savers
SVV
$1.62B
| $873K | ﹤0.01% |
126,584
+17,686
| +16% | +$163K |
|
1089
Shake Shack
SHAK
$2.65B
| $871K | ﹤0.01% |
9,884
-14,516
| -59% | -$1.58M |
|
1090
Heron Therapeutics
HRTX
$96.6M
| $868K | ﹤0.01% |
+394,600
| New | +$766K |
|
|
OLPX
1091
DELISTED
Olaplex Holdings
OLPX
| $862K | ﹤0.01% |
678,942
+89,698
| +15% | +$133K |
|
1092
NovoCure
NVCR
$1.82B
| $859K | ﹤0.01% |
48,212
-204,942
| -81% | -$4.65M |
|
1093
HDFC Bank
HDB
$123B
| $855K | ﹤0.01% |
25,742
| – | – |
|
1094
NeoGenomics
NEO
$2.07B
| $853K | ﹤0.01% |
89,910
-121,522
| -57% | -$1.52M |
|
1095
Oric Pharmaceuticals
ORIC
$1.14B
| $852K | ﹤0.01% |
152,700
+4,900
| +3% | +$42.8K |
|
|
HONE
1096
DELISTED
HarborOne Bancorp
HONE
| $848K | ﹤0.01% |
81,800
+3,616
| +5% | +$41.4K |
|
1097
Albertsons Companies
ACI
$5.64B
| $843K | ﹤0.01% |
38,324
+2,024
| +6% | +$41.8K |
|
1098
Monte Rosa Therapeutics
GLUE
$1.34B
| $798K | ﹤0.01% |
172,078
-48,018
| -22% | -$294K |
|
1099
Allogene Therapeutics
ALLO
$635M
| $796K | ﹤0.01% |
545,388
| – | – |
|
1100
Prothena Corp
PRTA
$432M
| $776K | ﹤0.01% |
62,694
-2,000
| -3% | -$28.3K |
|
Similar funds
VAM
TD Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, TD Asset Management held 1,291 positions worth $109B, down 3.9% from $113B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
TD Asset Management's Q1 2025 filing shows 49 new, 537 increased, 574 reduced and 75 closed positions. Its largest new stake was iShares MSCI South Korea ETF: 828,532 shares worth $44.8M. The largest sale was UnitedHealth, an estimated $450M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- TD Asset Management's largest Q1 2025 buy was iShares MSCI South Korea ETF: 828,532 shares worth $44.8M.
- TD Asset Management added most to Booking.com in Q1 2025, an estimated $323M increase.
- TD Asset Management's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $450M.
- TD Asset Management fully exited Novo Nordisk in Q1 2025, selling an estimated $51.5M.
- TD Asset Management's ten largest holdings make up 25% of its $109B portfolio in Q1 2025.
- TD Asset Management opened 49 new positions and closed 75 in Q1 2025.
- TD Asset Management's portfolio value fell 3.9% quarter-over-quarter to $109B.
Based on TD Asset Management's 13F filing for Q1 2025, filed 7 May 2025.